Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

LGND

Ligand Pharmaceuticals, Inc.

Apr 17 • 04:00PM ET

78.87

Dollar change -1.05
Percentage change -1.31	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IJR VTI IWM VB VBR VXF IJS PJP IWN IBB

Index	RUT	P/E	27.19	EPS (ttm)	2.90	Insider Own	6.22%	Shs Outstand	17.56M	Perf Week	-2.36%
Market Cap	1.40B	Forward P/E	14.07	EPS next Y	5.60	Insider Trans	-0.18%	Shs Float	16.60M	Perf Month	9.33%
Income	52.15M	PEG	1.36	EPS next Q	0.89	Inst Own	92.15%	Short Float	4.05%	Perf Quarter	11.30%
Sales	131.31M	P/S	10.64	EPS this Y	-26.86%	Inst Trans	-0.32%	Short Ratio	4.04	Perf Half Y	39.79%
Book/sh	39.92	P/B	1.98	EPS next Y	25.83%	ROA	6.94%	Short Interest	0.67M	Perf Year	4.16%
Cash/sh	9.62	P/C	8.20	EPS next 5Y	20.00%	ROE	8.29%	52W Range	49.24 - 94.57	Perf YTD	10.43%
Dividend Est.	-	P/FCF	30.96	EPS past 5Y	-13.18%	ROI	7.38%	52W High	-16.60%	Beta	1.00
Dividend TTM	-	Quick Ratio	12.72	Sales past 5Y	-3.89%	Gross Margin	67.06%	52W Low	60.17%	ATR (14)	2.49
Dividend Ex-Date	Jul 02, 2010	Current Ratio	14.15	EPS Y/Y TTM	253.69%	Oper. Margin	7.48%	RSI (14)	57.11	Volatility	2.23% 2.82%
Employees	58	Debt/Eq	0.01	Sales Y/Y TTM	-40.20%	Profit Margin	39.72%	Recom	1.20	Target Price	116.80
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	199.40%	Payout	0.00%	Rel Volume	1.08	Prev Close	79.92
Sales Surprise	9.58%	EPS Surprise	108.87%	Sales Q/Q	-44.22%	Earnings	Feb 27 BMO	Avg Volume	166.38K	Price	78.87
SMA20	4.23%	SMA50	4.88%	SMA200	17.93%	Trades		Volume	179,843	Change	-1.31%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-14-21	Resumed	Stephens	Overweight	$200
Feb-04-21	Reiterated	H.C. Wainwright	Buy	$229 → $310
Oct-06-20	Initiated	Barclays	Overweight	$156
Mar-24-20	Downgrade	Argus	Buy → Hold
Mar-10-20	Initiated	Guggenheim	Neutral
Feb-06-20	Initiated	The Benchmark Company	Buy	$135
Sep-19-19	Upgrade	Barclays	Equal Weight → Overweight	$110 → $132
Jun-11-19	Initiated	Barclays	Equal Weight	$131
May-03-19	Reiterated	H.C. Wainwright	Buy	$254 → $214
Mar-06-19	Reiterated	H.C. Wainwright	Buy	$281 → $254
Oct-29-18	Upgrade	ROTH Capital	Neutral → Buy
Oct-02-18	Reiterated	H.C. Wainwright	Buy	$270 → $280
Sep-11-18	Reiterated	Argus	Buy	$260 → $300
Aug-17-18	Initiated	Goldman	Neutral	$256
Aug-08-18	Downgrade	ROTH Capital	Buy → Neutral
Jun-21-18	Initiated	Argus	Buy	$260
Dec-27-17	Reiterated	H.C. Wainwright	Buy	$163 → $169
Sep-05-17	Resumed	H.C. Wainwright	Buy	$150
Oct-05-16	Reiterated	H.C. Wainwright	Buy	$146 → $160
Aug-05-16	Downgrade	Deutsche Bank	Hold → Sell	$104 → $110

Show Previous Ratings

Apr-17-24 09:55AM	Wall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know (Zacks)
Apr-08-24 08:15AM	Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference (Business Wire)
Apr-05-24 06:00PM	Ligand Pharmaceuticals (LGND) Stock Dips While Market Gains: Key Facts (Zacks)
Apr-04-24 09:30AM	Wall Street Analysts Think Ligand (LGND) Is a Good Investment: Is It? (Zacks)
09:00AM	Investors Heavily Search Ligand Pharmaceuticals Incorporated (LGND): Here is What You Need to Know (Zacks)
09:00AM	Loading…
Apr-03-24 09:00AM	Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI (Business Wire)
Apr-01-24 06:15PM	Ligand Pharmaceuticals (LGND) Ascends While Market Falls: Some Facts to Note (Zacks)
Mar-28-24 11:30AM	Ligand (LGND) Down 15.5% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-26-24 06:15PM	Ligand Pharmaceuticals (LGND) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Mar-21-24 09:00AM	Here is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) is a Trending Stock (Zacks)
Mar-20-24 06:00PM	Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to Consider (Zacks)
Mar-19-24 09:30AM	Ligand (LGND) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
Mar-14-24 06:00PM	Ligand Pharmaceuticals (LGND) Declines More Than Market: Some Information for Investors (Zacks)
Mar-07-24 09:00AM	Is Trending Stock Ligand Pharmaceuticals Incorporated (LGND) a Buy Now? (Zacks)
Mar-05-24 04:01PM	Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference (Business Wire)
08:00AM	Loading…
Mar-04-24 08:00AM	Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-29-24 09:30AM	Wall Street Analysts See Ligand (LGND) as a Buy: Should You Invest? (Zacks) -5.93%
Feb-28-24 07:34AM	Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges (Zacks) -5.44%
Feb-27-24 07:00AM	Ligand Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire) +19.86%
Feb-22-24 04:01PM	Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa (Business Wire)
Feb-16-24 08:00AM	Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires (Business Wire)
Feb-13-24 04:01PM	Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 (Business Wire) -6.13%
Feb-01-24 05:00PM	Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-10-24 07:30PM	Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene (GlobeNewswire)
Jan-05-24 04:30PM	U.S. Food and Drug Administration Approves ZELSUVMI as a First-in-Class Medication for the Treatment of Molluscum Contagiosum (Business Wire)
Dec-12-23 12:01PM	Ligand Holds Investor and Analyst Day; Provides Update on Portfolio Progress and Recent Transactions; Introduces 2024 Guidance (Business Wire)
09:00AM	Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient Quality of Life (GlobeNewswire)
09:00AM	Sermonix Pharmaceuticals Shares Pharmacokinetic and Baseline Genomic Clinical Data Tied to ELAINE Lasofoxifene Trials of Patients With ESR1 Mutations (GlobeNewswire)
Dec-11-23 09:00AM	Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of Oncology (GlobeNewswire)
Dec-06-23 04:02PM	Ligand to Host Investor and Analyst Day on December 12, 2023 in New York City (Business Wire)
08:20AM	Loading…
Dec-01-23 08:20AM	Palvella Therapeutics and Ligand Pharmaceuticals Expand Strategic Partnership to Accelerate Phase 3 Development of QTORIN rapamycin for Microcystic Lymphatic Malformations and Additional High Unmet Need Clinical Indications (GlobeNewswire)
Nov-28-23 09:01AM	Sermonix Pharmaceuticals Announces Five Abstracts Accepted for Presentation at 2023 San Antonio Breast Cancer Symposium (GlobeNewswire)
Nov-09-23 04:47PM	Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 04:01PM	Ligand Reports Third Quarter 2023 Financial Results (Business Wire)
Nov-06-23 09:00AM	Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete Remission in a Metastatic Breast Cancer Patient Participating in ELAINE-1 Trial (GlobeNewswire)
Nov-01-23 08:00AM	Ligand Acquires Royalty on Sanofis TZIELD for $20 Million (Business Wire)
Oct-25-23 04:01PM	Ligand To Report Third Quarter 2023 Financial Results On November 8 (Business Wire)
Oct-18-23 08:00AM	Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026 (GlobeNewswire)
Oct-09-23 06:15PM	Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to Consider (Zacks)
Oct-03-23 06:00PM	Ligand Pharmaceuticals (LGND) Stock Moves -0.71%: What You Should Know (Zacks)
Oct-02-23 09:00AM	Sermonix Pharmaceuticals Shares Results of EQUALS 2 Survey on Vaginal and Sexual Health in Patients with ER+/HER2- Metastatic Breast Cancer (GlobeNewswire)
09:00AM	Sermonix Pharmaceuticals Announces Results of ELAINE-1 Exploratory Analysis Evaluating Effect of Patient Characteristics on Baseline Genitourinary Symptoms (GlobeNewswire)
Sep-27-23 09:00AM	Ligand Acquires Assets of Novan, Inc. for $12.2 Million (Business Wire)
Sep-26-23 05:05PM	Ligand Appoints Martine Zimmermann to its Board of Directors (Business Wire)
Sep-22-23 09:00AM	Ligands Partner Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze® (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (Business Wire)
Sep-21-23 09:20AM	Ligands Partner Travere Therapeutics Announces Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI® Demonstrating Long-Term Kidney Function Preservation in IgA Nephropathy; Narrowly Missing eGFR Total Slope Endpoint versus Active Control (Business Wire)
Sep-18-23 05:17PM	Ligand Spins Out and Merges Pelican Subsidiary with Primordial Genetics to Form Primrose Bio (Business Wire)
Sep-01-23 10:02PM	Ligand Pharmaceuticals Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Aug-08-23 04:01PM	Ligand Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-27-23 01:30PM	Ligands Collaborator Merck Announces V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Met Key Immunogenicity and Safety Endpoints in Two Phase 3 Trials (Business Wire)
Jul-25-23 04:30PM	Ligand To Report Second Quarter 2023 Financial Results On August 8 (Business Wire)
Jul-17-23 08:59AM	Ligand Offers $15 Million to Acquire Assets of Novan, Inc. (Business Wire)
08:45AM	Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection (GlobeNewswire)
Jun-29-23 09:00AM	Sermonix Pharmaceuticals to Present Two Posters at The Menopause Society 2023 Annual Meeting (GlobeNewswire)
Jun-21-23 08:00PM	LGND: Lowering target price to $81.00 (Argus Research)
Jun-09-23 09:40AM	Is Ligand Pharmaceuticals (LGND) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jun-06-23 11:40AM	LGND or ILMN: Which Is the Better Value Stock Right Now? (Zacks)
11:10AM	UnitedHealth (UNH) Intends to Buy Amedisys to Boost Home-Health (Zacks)
Jun-05-23 11:49AM	Oncorus (ONCR) Dips 37% on Layoff Plan & Bankruptcy Threat (Zacks) -5.72%
09:01AM	Sermonix Pharmaceuticals Shares ASCO Poster Presentation on Longer Patient Follow-up Results for ELAINE-2 Study in ESR1-mutated Metastatic Breast Cancer (GlobeNewswire)
Jun-02-23 12:39PM	FDA Expands AstraZeneca (AZN) Lynparza Label in Prostate Cancer (Zacks) +5.77%
12:35PM	Ionis (IONS) Posts Two-Year Upbeat Data From HAE Drug Study (Zacks)
Jun-01-23 11:29AM	Biohaven (BHVN) Stock up 8% on Encouraging Pipeline Updates (Zacks)
May-30-23 07:01PM	3 Stocks That Smart Investors Should Be Flocking to Now (InvestorPlace)
May-25-23 05:00PM	Sermonix Pharmaceuticals to Share Longer Patient Follow-up Results for ELAINE-2 in Poster Presentation at ASCO 2023 (GlobeNewswire)
May-24-23 09:55AM	Wall Street Analysts Think Ligand (LGND) Could Surge 44.42%: Read This Before Placing a Bet (Zacks)
09:40AM	Has Anebulo Pharmaceuticals (ANEB) Outpaced Other Medical Stocks This Year? (Zacks)
May-17-23 01:59PM	Viking (VKTX) Up 12% as VKTX-2809 Meets Goals in NASH Study (Zacks)
08:07AM	Zacks.com featured highlights include J.B. Hunt Transport Services, Archer-Daniels-Midland, NVIDIA, Tractor Supply and AmerisourceBergen (Zacks)
May-16-23 09:56AM	Here's Why Biogen (BIIB) Stock is Up 12.6% This Year So Far (Zacks)
07:30AM	Ligands Partner Viking Therapeutics Announces Positive Top-Line Results from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) (Business Wire)
07:00AM	Load Up on These 5 Exceptional Relative Price Strength Stocks (Zacks)
May-12-23 12:08PM	ImmunoGen (IMGN) Stock Surges 230% in a Month: Here's Why (Zacks)
11:34AM	FDA Rejects ImmunityBio's (IBRX) Bladder Cancer Therapy Filing (Zacks)
May-11-23 12:25PM	Jazz (JAZZ) Lags on Q1 Earnings & Sales, Reaffirms '23 View (Zacks)
May-08-23 12:32PM	Ligand (LGND) Up 3% on Raised '23 View, Beats on Q1 Earnings (Zacks)
09:55AM	Wall Street Analysts Believe Ligand (LGND) Could Rally 38.66%: Here's is How to Trade (Zacks)
May-06-23 10:13AM	Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? (Simply Wall St.)
May-05-23 10:00AM	Best Momentum Stocks to Buy for May 5th (Zacks)
May-04-23 05:45PM	Ligand Pharmaceuticals (LGND) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
04:01PM	Ligand Reports First Quarter 2023 Financial Results (Business Wire)
06:26AM	10 Best Small-Cap Growth Stocks to Buy Now (Insider Monkey)
May-02-23 08:30PM	2 Medical Stocks to Buy Before Earnings (Zacks)
12:06PM	Vertex (VRTX) Q1 Earnings Top Estimates, Revenues Up Y/Y (Zacks)
11:40AM	LGND vs. REGN: Which Stock Is the Better Value Option? (Zacks)
Apr-28-23 02:04PM	Intercept (ICPT) Q1 Earnings Miss Estimates, Revenues Up Y/Y (Zacks)
Apr-27-23 09:04AM	Alkermes (ALKS) Q1 Earnings & Revenues Beat Estimates (Zacks)
Apr-26-23 08:00PM	LGND: Lowering target price to $81.00 (Argus Research)
Apr-24-23 04:01PM	Ligand to Report First Quarter 2023 Financial Results on May 4, 2023 (Business Wire)
Apr-20-23 09:55AM	Does Ligand (LGND) Have the Potential to Rally 41.24% as Wall Street Analysts Expect? (Zacks)
Apr-19-23 08:30AM	Here's How Much a $1000 Investment in Ligand Pharmaceuticals Made 10 Years Ago Would Be Worth Today (Zacks)
Apr-18-23 12:56PM	Vaxcyte (PCVX) Up on Pneumococcal Conjugate Vaccine Data (Zacks)
Apr-17-23 01:13PM	Bristol Myers (BMY), TSVT Application for Abecma Accepted (Zacks)
09:40AM	Is Hologic (HOLX) Outperforming Other Medical Stocks This Year? (Zacks)
Apr-14-23 01:48PM	Merck's (MRK) Keytruda sBLA Accepted by FDA for Gastric Cancer (Zacks)
Apr-13-23 06:28AM	Are Investors Undervaluing Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) By 41%? (Simply Wall St.)
Apr-07-23 06:40PM	Tillys, American Public Education Stock See Action From Activist Investors (Barrons.com)
Apr-06-23 10:23AM	Here's Why You Should Add Ligand (LGND) Stock to Your Portfolio (Zacks)
Apr-04-23 12:02PM	Oncternal (ONCT) Down on Restructuring Plan to Extend Runway (Zacks)
09:55AM	Wall Street Analysts Predict a 53.67% Upside in Ligand (LGND): Here's What You Should Know (Zacks)

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Davis Todd C	Chief Executive Officer	Mar 25 '24	Option Exercise	57.39	16,015	919,147	120,160	Mar 27 05:47 PM
Aryeh Jason	Director	Mar 05 '24	Option Exercise	39.35	2,893	113,840	74,422	Mar 06 05:28 PM
Sabba Stephen L	Director	Mar 05 '24	Option Exercise	0.00	2,893	0	30,819	Mar 07 01:27 PM
Sabba Stephen L	Director	Mar 05 '24	Sale	74.30	1,893	140,650	28,926	Mar 07 01:27 PM
Espinoza Octavio	Chief Financial Officer	Feb 28 '24	Option Exercise	56.62	1,264	71,564	29,895	Feb 29 06:50 PM
Espinoza Octavio	Chief Financial Officer	Feb 28 '24	Sale	88.46	140	12,384	29,755	Feb 29 06:50 PM
Davis Todd C	CHIEF EXECUTIVE OFFICER	Sep 22 '23	Buy	59.38	4,000	237,529	73,090	Sep 25 04:44 PM
KOZARICH JOHN W	Director	May 16 '23	Sale	77.20	4,444	343,081	38,488	May 18 05:18 PM
Sabba Stephen L	Director	May 10 '23	Option Exercise	0.00	6,408	0	32,192	May 12 03:43 PM
Sabba Stephen L	Director	May 10 '23	Sale	77.13	6,408	494,225	25,784	May 12 03:43 PM
KOZARICH JOHN W	Director	May 08 '23	Option Exercise	18.82	6,408	120,599	48,621	May 10 07:15 PM
KOZARICH JOHN W	Director	May 08 '23	Sale	76.56	6,408	490,628	42,213	May 10 07:15 PM

Open in Screener

NXPI

NXP Semiconductors NV

Apr 17 • 04:00PM ET

226.92

Dollar change -3.76
Percentage change -1.63	%

Technology • Semiconductors • Netherlands • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

NXPI NXP Semiconductors NV daily Stock Chart

Held by: VOO QQQ IVV SOXX JEPI VGT SMH SOXL VYM RSP

Index	NDX, S&P 500	P/E	21.17	EPS (ttm)	10.72	Insider Own	0.12%	Shs Outstand	257.19M	Perf Week	-5.87%
Market Cap	58.20B	Forward P/E	14.39	EPS next Y	15.77	Insider Trans	-18.03%	Shs Float	256.16M	Perf Month	-4.10%
Income	2.80B	PEG	2.31	EPS next Q	3.18	Inst Own	92.52%	Short Float	1.84%	Perf Quarter	10.43%
Sales	13.28B	P/S	4.38	EPS this Y	-1.56%	Inst Trans	-2.39%	Short Ratio	2.02	Perf Half Y	13.58%
Book/sh	33.61	P/B	6.75	EPS next Y	14.31%	ROA	11.37%	Short Interest	4.72M	Perf Year	30.03%
Cash/sh	16.65	P/C	13.63	EPS next 5Y	9.17%	ROE	34.76%	52W Range	155.31 - 264.26	Perf YTD	-1.20%
Dividend Est.	4.28 (1.89%)	P/FCF	21.78	EPS past 5Y	9.82%	ROI	14.70%	52W High	-14.13%	Beta	1.58
Dividend TTM	4.06 (1.79%)	Quick Ratio	1.39	Sales past 5Y	7.95%	Gross Margin	54.75%	52W Low	46.11%	ATR (14)	6.86
Dividend Ex-Date	Mar 20, 2024	Current Ratio	1.91	EPS Y/Y TTM	1.72%	Oper. Margin	28.16%	RSI (14)	38.63	Volatility	2.76% 2.38%
Employees	34200	Debt/Eq	1.32	Sales Y/Y TTM	0.54%	Profit Margin	21.07%	Recom	2.09	Target Price	247.99
Option/Short	Yes / Yes	LT Debt/Eq	1.20	EPS Q/Q	-3.03%	Payout	37.47%	Rel Volume	0.83	Prev Close	230.68
Sales Surprise	0.73%	EPS Surprise	1.60%	Sales Q/Q	3.32%	Earnings	Apr 29 AMC	Avg Volume	2.34M	Price	226.92
SMA20	-6.01%	SMA50	-5.88%	SMA200	5.79%	Trades		Volume	1,935,384	Change	-1.63%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-16-24	Initiated	Evercore ISI	Outperform	$300
Mar-12-24	Reiterated	TD Cowen	Outperform	$270 → $300
Feb-07-24	Reiterated	TD Cowen	Outperform	$250 → $270
Jan-23-24	Initiated	Cantor Fitzgerald	Overweight	$260
Jan-18-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$255
Jan-16-24	Upgrade	Barclays	Equal Weight → Overweight	$200 → $260
Dec-05-23	Reiterated	TD Cowen	Outperform	$240 → $250
Nov-08-23	Downgrade	Citigroup	Neutral → Sell	$216 → $150
Jul-20-23	Initiated	Wolfe Research	Peer Perform
Jan-10-23	Upgrade	UBS	Sell → Neutral	$160 → $167
Nov-16-22	Initiated	Credit Suisse	Neutral	$195
Oct-24-22	Downgrade	Barclays	Overweight → Equal Weight	$200 → $140
Apr-19-22	Downgrade	Citigroup	Buy → Neutral	$240 → $190
Jan-20-22	Downgrade	Piper Sandler	Overweight → Neutral	$235 → $210
Jan-12-22	Reiterated	Barclays	Overweight	$230 → $250
Jan-10-22	Reiterated	BofA Securities	Buy	$255 → $270
Dec-08-21	Initiated	UBS	Sell	$170
Sep-29-21	Downgrade	Bernstein	Outperform → Mkt Perform	$245 → $230
Sep-03-21	Initiated	Argus	Buy	$260
Jul-15-21	Downgrade	Mizuho	Buy → Neutral	$225 → $220

Show Previous Ratings

Apr-17-24 10:05PM	Automotive IDM competition intensifies (DigiTimes)
Apr-11-24 08:00AM	NXP Semiconductors Announces Conference Call to Review First Quarter 2024 Financial Results (GlobeNewswire)
04:50AM	Q4 Rundown: NXP Semiconductors (NASDAQ:NXPI) Vs Other Analog Semiconductors Stocks (StockStory)
Apr-10-24 09:00AM	Is Trending Stock NXP Semiconductors N.V. (NXPI) a Buy Now? (Zacks)
Apr-09-24 05:00AM	Winners And Losers Of Q4: Skyworks Solutions (NASDAQ:SWKS) Vs The Rest Of The Analog Semiconductors Stocks (StockStory)
06:00PM	Loading…
Apr-08-24 06:00PM	NXP Semiconductors (NXPI) Gains As Market Dips: What You Should Know (Zacks)
Apr-03-24 09:30AM	Brokers Suggest Investing in NXP (NXPI): Read This Before Placing a Bet (Zacks)
Apr-02-24 04:30AM	Analog Semiconductors Stocks Q4 Teardown: Impinj (NASDAQ:PI) Vs The Rest (StockStory)
Apr-01-24 12:01PM	NXP Semiconductors (NXPI) Adds S32 CoreRide to Auto Portfolio (Zacks)
Mar-31-24 04:44AM	Warren Buffett Has $159 Billion Invested in These 8 Artificial Intelligence (AI) Stocks (Motley Fool)
Mar-28-24 04:06PM	11 Undervalued Semiconductor Stocks To Buy According to Hedge Funds (Insider Monkey)
04:00AM	NXP Breaks Through Integration Barriers for Software-Defined Vehicle Development with Open S32 CoreRide Platform (GlobeNewswire)
Mar-27-24 05:57PM	20 Biggest Semiconductor Companies in the US (Insider Monkey)
04:21PM	15 Biggest Semiconductor Companies and Suppliers in Europe (Insider Monkey)
Mar-22-24 06:15PM	NXP Semiconductors (NXPI) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
04:30PM	Loading…
Mar-19-24 04:30PM	NXP Publishes Annual Corporate Sustainability Report, Highlights Progress Toward Environmental, Social and Governance Goals (GlobeNewswire)
07:02AM	NXP Semiconductors NV's Dividend Analysis (GuruFocus.com)
Mar-18-24 06:00PM	NXP Collaborates with NVIDIA to Accelerate AI Deployment with Integration of TAO Toolkit with NXP Edge Devices (GlobeNewswire)
09:09AM	Top 20 Largest Countries In Asia By Area In 2024 (Insider Monkey)
Mar-14-24 02:52PM	Impinj Stock Spikes as Company Settles RFID-Tag Patent Fight (Barrons.com)
Mar-12-24 06:15PM	NXP Semiconductors (NXPI) Laps the Stock Market: Here's Why (Zacks)
01:26PM	Trade Tracker: Jim Lebenthal buys New York Community Bancorp and trims NXP Semiconductors (CNBC TV)
Mar-11-24 04:57PM	Ta-Da! 3 Picks to Turn $1,000 Into $8,000 in Annual Passive Income (InvestorPlace)
Mar-08-24 12:32PM	Dutch workers at semiconductor maker NXP to go on strike (Reuters)
Mar-07-24 08:00AM	NXP Semiconductors Announces Quarterly Dividend (GlobeNewswire)
Mar-06-24 11:30AM	Why Is NXP (NXPI) Up 11.4% Since Last Earnings Report? (Zacks)
Feb-23-24 12:04AM	Decoding NXP Semiconductors NV (NXPI): A Strategic SWOT Insight (GuruFocus.com)
Feb-16-24 03:47PM	25 Most Valuable Tech Companies Outside The US (Insider Monkey)
Feb-13-24 05:00PM	The 3 EV Stocks That Could Make Your February Unforgettable (InvestorPlace)
Feb-12-24 02:13PM	Final Trades: Bitcoin, NXP Semiconductors and Diamondback Energy (CNBC TV)
08:46AM	Loading…
Feb-07-24 08:46AM	NXP Semiconductors N.V. (NASDAQ:NXPI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-06-24 03:19PM	Analyst Report: NXP Semiconductors N.V. (Morningstar Research)
01:52PM	NXP Semiconductors Stock Jumps To Higher RS Level; Q4 Results Beat (Investor's Business Daily)
01:15PM	NXP Semiconductors (NXPI) Q4 2023 Earnings Call Transcript (Motley Fool)
01:07PM	NXP Semiconductors (NXPI) Q4 Earnings Beat, Revenues Rise Y/Y (Zacks)
06:34AM	NXP Semiconductors NV (NXPI) Posts Modest Revenue Growth Amidst Market Challenges (GuruFocus.com)
Feb-05-24 06:00PM	NXP (NXPI) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:37PM	Chipmaker NXP forecasts profit above estimates on automotive strength (Reuters)
04:35PM	NXP: Q4 Earnings Snapshot (Associated Press Finance)
04:20PM	No Surprises In NXP Semiconductors's (NASDAQ:NXPI) Q4 Sales Numbers But Quarterly Guidance Underwhelms (StockStory)
04:10PM	NXP Semiconductors Reports Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
Feb-04-24 02:01AM	NXP Semiconductors (NXPI) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
Feb-01-24 04:28PM	BetterInvesting Magazine Update on NXP Semiconductors N.V. and Comcast Corp. (PR Newswire)
11:13AM	NXP Semiconductors (NXPI) to Post Q4 Earnings: What's in Store? (Zacks)
Jan-31-24 09:15AM	Unveiling NXP (NXPI) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
07:30AM	No. 1 Ranked NXP Stock Jumps 81 RS Rating, Passing Milestone (Investor's Business Daily)
Jan-30-24 06:15PM	NXP Semiconductors (NXPI) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Jan-29-24 10:00AM	NXP Semiconductors (NXPI) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Jan-26-24 09:13AM	This Chip Stock Missed the Rally. Now It Looks Like a Buy. (Barrons.com)
08:40AM	NXP Semiconductors Can Buck Auto Weakness. The Stock Looks Like a Buy. (Barrons.com)
Jan-24-24 07:20PM	7 Tech Stocks That Also Bring in Attractive Passive Income (InvestorPlace)
06:15PM	NXP Semiconductors (NXPI) Stock Sinks As Market Gains: Here's Why (Zacks)
Jan-23-24 06:33PM	Analyst Report: NXP Semiconductors N.V. (Morningstar Research)
08:00AM	HONEYWELL TRANSFORMS BUILDING MANAGEMENT WITH FIRST-OF-ITS-KIND TECHNOLOGY (PR Newswire)
Jan-18-24 10:19AM	Nvidia, AMD Stocks Hit Record High After Chipmaker TSMC Forecasts Rebound (The Wall Street Journal)
10:01AM	Nvidia, AMD Stocks Hits Record High After Chipmaker TSMC Forecasts Rebound (The Wall Street Journal)
09:51AM	Nvidia, Other Chip Stocks Rise After Heavyweight TSMC Forecasts Rebound (The Wall Street Journal)
01:18AM	Microsoft upgraded to Outperform, price target raised to $471: 4 big analyst picks (Investing.com)
Jan-16-24 04:10PM	The Top 3 Stocks to Buy for a Profitable Eco-Friendly Portfolio (InvestorPlace)
10:30AM	NXP Semiconductors' (NXPI) Strong Portfolio Aids Honeywell Deal (Zacks)
Jan-12-24 06:15PM	NXP Semiconductors (NXPI) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
09:32AM	NXP Semiconductors (NXPI) Aids Automotive Portfolio With SAF86xx (Zacks)
Jan-11-24 08:00AM	HONEYWELL AND NXP SEMICONDUCTORS COLLABORATE TO HELP ENHANCE BUILDING ENERGY MANAGEMENT (PR Newswire)
Jan-09-24 04:53PM	Why NXP (NXPI) is Poised to Beat Earnings Estimates Again (Zacks)
04:10PM	NXP Semiconductors Announces Conference Call to Review Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
12:00PM	NXP Extends Industry-First 28 nm RFCMOS Radar One-Chip Family to Enable ADAS Architectures for Software-Defined Vehicles (GlobeNewswire)
06:00AM	Investing in the Future of AI Chips: Top 3 Semiconductor Stocks to Consider in 2024 (InvestorPlace)
05:01AM	Winners And Losers Of Q3: NXP Semiconductors (NASDAQ:NXPI) Vs The Rest Of The Analog Semiconductors Stocks (StockStory)
Jan-04-24 06:28PM	Analyst Report: NXP Semiconductors N.V. (Morningstar Research)
11:44AM	Mobileye Plunges as Full-Year Revenue Forecast Falls Short (Bloomberg)
11:36AM	NXP Semiconductors (NXPI) Stock Trades Down, Here Is Why (StockStory)
Dec-19-23 06:36PM	Why These 3 EV Charging Stocks Should Be On Your Radar in 2024 (InvestorPlace)
06:15PM	Here's Why NXP Semiconductors (NXPI) Gained But Lagged the Market Today (Zacks)
Dec-15-23 01:01PM	Insider Sell Alert: EVP Human Resources Christopher Jensen Sells 7,000 Shares of NXP ... (GuruFocus.com)
Dec-14-23 06:27PM	Analyst Report: NXP Semiconductors N.V. (Morningstar Research) +5.13%
Dec-13-23 08:57PM	Cultivating intelligent edge: NXP's three-dimensional deep deployments (DigiTimes)
08:40PM	NXP sees growth from increased chip content in cars (DigiTimes)
03:05PM	Insider Sell Alert: EVP Global Sales Martino Ronald Sells 5,014 Shares of NXP Semiconductors NV ... (GuruFocus.com)
Dec-12-23 08:45PM	NXP gears up for IoT device boom (DigiTimes)
06:15PM	NXP Semiconductors (NXPI) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Dec-11-23 05:06AM	NXP Semiconductors NV's Dividend Analysis (GuruFocus.com)
Dec-06-23 11:30AM	Why Is NXP (NXPI) Up 10.8% Since Last Earnings Report? (Zacks)
Dec-05-23 06:15PM	NXP Semiconductors (NXPI) Declines More Than Market: Some Information for Investors (Zacks)
05:04PM	How NXP Semiconductors Stock Rose 18% Last Month (Motley Fool)
07:05AM	Insider Sell Alert: EVP & General Counsel Jennifer Wuamett Sells Shares of NXP Semiconductors NV (GuruFocus.com)
Dec-02-23 02:05PM	JP Morgans Top 15 Stock Picks for 2023 and Now (Insider Monkey)
Dec-01-23 09:44AM	NXP Semiconductors (NXPI) Boosts UWB Portfolio With New Devices (Zacks)
Nov-29-23 08:26PM	If You Can Only Buy One Semiconductor Stock in December, It Better Be One of These 3 Names (InvestorPlace)
Nov-28-23 03:00AM	NXP Introduces the Next Generation of Automotive Ultra-Wideband ICs Combining Secure Ranging and Short-Range Radar (GlobeNewswire)
Nov-21-23 10:12AM	Semiconductor R&D spending by company: Top 12 (Insider Monkey)
Nov-20-23 02:02AM	Analog Devices (ADI) Q4 Earnings: What To Expect (StockStory)
Nov-19-23 11:11AM	3 Top AI Stocks to Buy Beyond the "Magnificent Seven" (Motley Fool)
Nov-15-23 05:55PM	NXP Semiconductors Announces Quarterly Dividend (GlobeNewswire)
05:18PM	Chips Ahoy: 3 Semiconductor Stocks You Need to Buy Now (InvestorPlace)
Nov-14-23 05:10AM	Semiconductors Could Be a $1 Trillion Opportunity by 2030 -- 3 Stocks You Can Buy to Take Advantage (Motley Fool) +5.44%
Nov-13-23 06:03PM	11 Best European Stocks To Buy Now (Insider Monkey)
Nov-08-23 09:59AM	Snowflake upgraded, Lucid downgraded: Wall Street's top analyst calls (The Fly)
01:49AM	Luxury EV name Lucid slashed on cooling production guidance: 4 big analyst cuts (Investing.com)
12:03AM	The NXP Semiconductors NV (NXPI) Company: A Short SWOT Analysis (GuruFocus.com)
Nov-07-23 05:28PM	GlobalFoundries Posts Better-Than-Expected Earnings on Resilient Demand (Investopedia)

NXP Semiconductors NV is a holding company which engages in the provision of semiconductor solutions. It operates through the following geographical segments: China, Netherlands, United States, Singapore, Germany, Japan, South Korea, Malaysia, and Other Countries. The company was founded on August 2, 2006, and is headquartered in Eindhoven, the Netherlands.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jensen Christopher L	EVP Human Resources	Feb 29 '24	Sale	248.41	4,765	1,183,674	0	Feb 29 04:04 PM
SUMME GREGORY L	Director	Feb 28 '24	Sale	245.27	4,695	1,151,520	7,097	Feb 29 04:05 PM
Wuamett Jennifer	EVP & General Counsel	Feb 28 '24	Sale	244.78	4,000	979,102	33,769	Feb 29 04:05 PM
SUMME GREGORY L	Director	Feb 28 '24	Sale	245.27	3,000	735,796	0	Feb 29 04:05 PM
Sievers Kurt	CEO & President	Feb 27 '24	Sale	252.06	21,991	5,543,051	186,437	Feb 29 04:03 PM
Wuamett Jennifer	EVP & General Counsel	Jan 02 '24	Sale	227.26	2,120	481,791	38,229	Jan 03 04:39 PM
Jensen Christopher L	EVP Human Resources	Dec 12 '23	Sale	221.00	7,000	1,547,000	4,765	Dec 13 04:04 PM
Sievers Kurt	CEO & President	Dec 11 '23	Sale	218.16	8,699	1,897,773	208,428	Dec 12 04:35 PM
Ronald Martino	EVP Global Sales	Dec 11 '23	Sale	216.43	5,014	1,085,180	15,541	Dec 12 04:36 PM
Betz William	EVP & CFO	Dec 01 '23	Sale	204.00	4,428	903,312	1,518	Dec 04 04:46 PM
Wuamett Jennifer	EVP & General Counsel	Dec 01 '23	Sale	204.00	2,000	408,000	40,349	Dec 04 04:47 PM
Jensen Christopher L	EVP Human Resources	Nov 02 '23	Option Exercise	0.00	1,089	0	3,616	Nov 03 08:51 AM
Ronald Martino	EVP Global Sales	Nov 02 '23	Option Exercise	0.00	678	0	16,671	Nov 03 08:50 AM
Sievers Kurt	CEO & President	Nov 02 '23	Option Exercise	0.00	6,778	0	171,962	Nov 03 08:50 AM
Wuamett Jennifer	EVP & General Counsel	Nov 02 '23	Option Exercise	0.00	1,065	0	30,593	Nov 03 08:50 AM
Micallef Andrew	EVP Global Operations	Nov 02 '23	Option Exercise	0.00	920	0	4,220	Nov 03 08:50 AM
Betz William	EVP & CFO	Nov 02 '23	Option Exercise	0.00	1,210	0	4,347	Nov 03 08:51 AM
Betz William	EVP & CFO	Nov 01 '23	Option Exercise	0.00	1,811	0	3,760	Nov 03 08:51 AM
Micallef Andrew	EVP Global Operations	Nov 01 '23	Option Exercise	0.00	1,449	0	3,982	Nov 03 08:50 AM
Wuamett Jennifer	EVP & General Counsel	Nov 01 '23	Option Exercise	0.00	1,580	0	30,150	Nov 03 08:50 AM
Sievers Kurt	CEO & President	Nov 01 '23	Option Exercise	0.00	9,746	0	170,206	Nov 03 08:50 AM
Jensen Christopher L	EVP Human Resources	Nov 01 '23	Option Exercise	0.00	1,580	0	3,137	Nov 03 08:51 AM
Wuamett Jennifer	EVP & General Counsel	Oct 27 '23	Option Exercise	0.00	1,652	0	29,221	Oct 30 08:42 AM
Ronald Martino	EVP Global Sales	Oct 27 '23	Option Exercise	0.00	563	0	17,623	Oct 30 08:43 AM
Sievers Kurt	CEO & President	Oct 27 '23	Option Exercise	0.00	8,258	0	164,715	Oct 30 08:41 AM
Betz William	EVP & CFO	Oct 27 '23	Option Exercise	0.00	657	0	2,175	Oct 30 08:40 AM
Jensen Christopher L	EVP Human Resources	Oct 27 '23	Option Exercise	0.00	1,165	0	1,993	Oct 30 08:41 AM
Wuamett Jennifer	EVP & General Counsel	Sep 15 '23	Option Exercise	86.25	8,394	723,982	38,963	Sep 18 05:24 PM
Wuamett Jennifer	EVP & General Counsel	Sep 15 '23	Sale	199.80	11,394	2,276,520	27,569	Sep 18 05:24 PM
Micallef Andrew	EVP Global Operations	Aug 03 '23	Option Exercise	0.00	1,583	0	3,081	Aug 04 04:22 PM
Southern Julie	Chair	Aug 02 '23	Buy	218.07	203	44,268	10,540	Aug 03 06:00 PM
Sievers Kurt	CEO & President	Aug 01 '23	Sale	223.40	20,890	4,666,826	156,457	Aug 02 04:38 PM
Sievers Kurt	CEO & President	Jul 28 '23	Option Exercise	0.00	2,604	0	178,689	Jul 31 05:37 PM
Ronald Martino	EVP Global Sales	Jul 28 '23	Option Exercise	0.00	1,158	0	17,342	Jul 31 05:35 PM
Jensen Christopher L	EVP Human Resources	Jul 28 '23	Option Exercise	0.00	434	0	934	Jul 31 05:33 PM
Betz William	EVP & CFO	Jul 27 '23	Sale	224.38	3,514	788,470	1,518	Jul 28 04:17 PM
Jensen Christopher L	EVP Human Resources	May 30 '23	Sale	185.00	9,696	1,793,760	500	May 31 04:20 PM
BONFIELD PETER L	Chair	May 24 '23	Option Exercise	0.00	1,482	0	17,224	May 26 08:14 AM
Foxx Anthony R	Director	May 24 '23	Option Exercise	0.00	1,482	0	2,194	May 26 08:13 AM
Olving Lena	Director	May 24 '23	Option Exercise	0.00	1,482	0	3,673	May 26 08:13 AM
Staiblin Jasmin	Director	May 24 '23	Option Exercise	0.00	1,482	0	5,817	May 26 08:14 AM
Chunyuan Gu	Director	May 24 '23	Option Exercise	0.00	1,482	0	1,482	May 26 08:11 AM
SUMME GREGORY L	Director	May 24 '23	Option Exercise	0.00	1,482	0	12,526	May 26 08:12 AM
Sundstrom Karl-Henrik	Director	May 24 '23	Option Exercise	0.00	1,482	0	3,679	May 26 08:12 AM
Southern Julie	Director	May 24 '23	Option Exercise	0.00	1,482	0	11,071	May 26 08:12 AM
CLAYTON ANNETTE K	Director	May 24 '23	Option Exercise	0.00	1,482	0	2,194	May 26 08:12 AM
Wuamett Jennifer	EVP & General Counsel	May 05 '23	Sale	166.52	15,000	2,497,800	30,569	May 08 04:26 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

LGND

Ligand Pharmaceuticals, Inc.

NXPI

NXP Semiconductors NV

Upgrade your FINVIZ experience